The present study examined whether unilateral stimulation of acetylcholine or dopamine receptors in the nucleus accumbens induces an asymmetry in dopamine transmission in the ventrolateral striatum. For this purpose, a microdialysis technique was used to measure dopamine release in both sides of the ventrolateral striatum following unilateral injections of carbachol (5 ¿¿g/0.5 j j l \ ) or a mixture of dopamine Dj and dopamine D 2 receptor agonists (l-phenyl-2,3,4,5-tetrahydro-ltf-3-benzazepine-7,8-diol 5 fig + quinpirole 10 ¿¿g/0.5 /xl) into the nucleus accumbens. The results show that carbachol injection increased dopamine release in the ipsilateral striatum without changing dopamine release in the contralateral striatum, whereas the dopamine D , / D 2 receptor agonist mixture injected unilaterally into the nucleus accumbens produced an increase followed by a decrease in dopamine release in the ipsilateral striatum, but only a decrease in dopamine release in the contralateral striatum. The biochemical effects of the cholinergic treatment greatly outlasted the drug-induced contralateral turning, whereas the biochemical effects of the dopaminergic treatment showed a good correlation with the drug-induced contralateral turning. The present study provides biochemical evidence that unilateral stimulation of acetylcholine or dopamine receptors in the nucleus accumbens elicits an asymmetry in dopaminergic activity in the ventrolateral striatum. The present study also provides biochemical evidence that two distinct neural substrates are involved in the effects of cholinergic and dopaminergic manipulation of the nucleus accumbens. S 0 0 1 4 -2 9 9 9 (9 6 )0 0 0 5 8 -1
Introduction
Asymmetry between the left and right nucleus accum bens results in unilateral turning in freely moving rats Colle and Wise, 1991; Messier et al., 1991a, b; McKenzie et al., 1991) . Such an asymmetry can be produced by unilateral stimulation of either acetyl choline or dopamine D, and D2 receptors (Saigusa et al., 1993 (Saigusa et al., , 1995 . The effects of these treatments are both similar and dissimilar. So, both treatments produce con tralateral turning which is inhibited by blockade of dopamine D, and D2 receptors in the ipsilateral, but not contralateral, ventrolateral striatum (Saigusa et al, 1993 (Saigusa et al, , 1995 . This, together with the fact that the nucleus accum bens projects directly and indirectly (via the ventral pal lidum) to the dopaminergic A 9 cell area (Groenewegen et al., 1991; Wouterlood et al, 1992; Zahm and Heimer, 1993) which, in turn, projects to the ipsilateral and con tralateral striatum (Fass and Butcher, 1981) , opens the possibility that unilateral stimulation of acetylcholine or dopamine receptors in the nucleus accumbens activates both the process of locomotion (known to be mediated by the nucleus accumbens) and the process of postural asym metry (known to be mediated by the striatum) (Koshikawa, 1994) .
However, unilateral stimulation of acetylcholine recep- N. fCushikawu et al. / European Journal of Pharmacology 303 (1996) 13-19 tors in the nucleus acc urn bens produces a stepping pattern that differs completely from that elicited by unilateral stimulation of dopamine receptors in this nucleus (Saigusa et al., 1995) . Moreover, intra-accumbens administration of anticholinergics could not pharmacologically inhibit the turning elicited by dopamine receptor stimulation and in tra-accumbens administration of dopamine receptor antag onists could not pharmacologically inhibit the turning elicited by acetylcholine receptor stimulation (Saigusa et al., 1995) . These data suggest that two different neurobiological substrates are involved in the contralateral turning elicited by unilateral stimulation of acetylcholine and dopamine receptors in the nucleus accumbens (Saigusa et aL, 1995) . Therefore, the goal of the present study was to analyse whether unilateral stimulation of dopamine or acetyl choline receptors in the nucleus accumbens differentially affects the release of dopamine in the ipsilateral and contralateral ventrolateral striatum. For this purpose, the microdialysis technique was used to measure dopamine release in both sides of the ventrolateral striatum following unilateral injections of a mixture of dopamine and D2 receptor agonists (SKF 38393 5 jjlg -h quinpirole 10 f i g / 0.5 fil) or carbachol (5 fig/Q .S ¡jl 1) into the nucleus accumbens.
Intracerehral microinjection and drugs
The drugs used were carbachol (Sigma), a non-selective ♦ acetylcholine receptor agonist; SKF 38393 hydrochloride ((± )-l-phenyl-2 ,3,4,5-tetrahydro-l tf-3-benzazepine-7,8diol hydrochloride, Research Biochemicals International), a dopamine Dj receptor agonist; and quinpirole hydrochlo ride (LY 171555, Research Biochemicals International), a dopamine D2/ D 3 receptor agonist. All drugs were dis solved in saline immediately before use. For unilateral intracerebral microinjections, the rats were held manually while the stylets were removed and the injection needles (31 gauge) were lowered through the guide cannulas so that they protruded 1.9 mm beyond the tip. The needles were connected to Hamilton syringes, and the drugs were given slowly in a volume of 0.5 fJL1 over 30 s, after which the needles were left in place for a further 30 s. The extent of diffusion, estimated from the spread of the same volume of dye (thionin), was less than I mm in diameter. The doses of the drugs have previously been found to be highly effective in eliciting contralateral turning (Saigusa et al., 1993 (Saigusa et al., , 1995 .
Dialysis and neurochemical measurements

Materials and methods
2,1. Animals and surgery
Male Wistar rats weighing 200-250 g were used throughout the experiments. They were housed in a tem perature-controlled environment and under a light (07:00-19:00 h)/dark (19:00-07:00 h) cycle with free access to food and water. Behavioural testing was performed be tween 13:00 h and 17:00 h. For stereotactic implantation of cannulas, the rats were anaesthetized intraperitoneally with sodium pentobarbitone (50 m g/kg) and placed in a stereo tactic apparatus. A guide cannula (0.5 mm o.d., 0,3 mm i.d.) for intracerebral injection was implanted into the nucleus accumbens (ant. 10.6 mm, vert. 3.2 mm, lat. 1.7 mm) and another guide cannula (0.5 mm o.d., 0.4 mm i.d.) for a dialysis probe was implanted into either the ipsilat eral or contralateral ventrolateral striatum in relation to the nucleus accumbens guide cannula (ant. 8.6 mm, vert. 3.5 mm, lat 4.0 mm) according to the atlas of Paxinos and Watson (1986) and secured to the skull with stainless screws and dental acrylic cement. The nucleus accumbens cannula was angled 2 0° from the mid-sagittal plane to avoid the ventricular system. Damage to the target site was minimized by implanting the tips of the guide cannulas just above the desired site. A wire stylet was placed in the guide cannula to prevent occlusion. The rats were then allowed to recover for a minimum of 7 days. The animals were used only once.
The dialysis probe technique assessed in the present study has been described and validated in previous studies of our group (Takada et al., 1993; Tomiyama et al., 1993) . Below, a short description is given. The stainless steel insert was removed from the guide cannula immediately before the experiment and replaced with a dialysis probe (2 mm length, 0.22 mm o.d., 50000 mol. wt, 'cut-off) so that only the dialysis tubing protruded from the tip. The rat was then placed in a circular chamber (40 cm diameter) with 30-cm high Perspex sides, and the inlet and outlet tubes were connected to a swivel attached to a counterbal anced beam.
The probe was perfused at a rate of 2.0 fi 1/min with modified Ringer solution (NaCl 147 mM, KC1 4 mM, CaCl2 1.2 mM, MgCl2 1.1 mM; pH 7.4), and the outflow was connected by Teflon tubing to an HPLC system (EICOM, Kyoto, Japan). Perfusate samples were taken every 25 min for quantification of dopamine. Drugs were not given via the microinjection cannula until the baseline concentration of dopamine had stabilized (at least 4 h after probe insertion). Baseline levels were the mean of the last three samples before drug injection. The probes had an in vitro recovery of 10-12% for dopamine, but the reported concentrations (pg/50 ¡i\ of dialysate) were not adjusted for recovery in vivo because these estimations are inaccu rate (Benveniste et al., 1989; Benveniste and Huttemeier, 1990; Lindefors et al., 1989) . Contralateral turnings (de fined as complete 360° turns) were counted visually by a trained observer who had no prior knowledge of the drug treatment. Observations were made during consecutive ipsilaterally or contralaterally to the unilateral injection of saline into the nucleus accumbens.
Effects o f unilateral injection o f carbachol on the release o f dopamine and production o f turning
Carbachol (5 /¿g/0.5 /¿l) injected unilaterally into the nucleus accumbens induced wide, contralateral turnings for a period of about 50 min (P < 0.01 versus respective saline controls, Newman-Keuls test); the number of turn ings reached a maximum 5 min after the injection and then decreased to zero about 50 min after the injection ( Fig.  2A) . The treatment increased dopamine release in the ipsilateral striatum throughout the whole measurement pe riod. This release reached a maximum about 75 min after the injection and then slowly decreased, although it did not reach baseline levels at the end of the measurement period (250 min). The treatment did not affect dopamine release in the contralateral striatum ( Fig. 2B ).
Effects o f unilateral injection o f SKF 38393 and quinpirole mixture on the release o f dopamine and produc tion o f turning
The mixture of dopamine D ,/D 2 receptor agonists (SKF 38393 5 fig 4-quinpirole 10 fxg/0.5 /xl) injected unilaterally into the nucleus accumbens induced tight head-to-tail, contralateral turnings for a period of about 120 min ( P < 0.01 versus respective saline controls, New man-Keuls test); the number of turnings reached a maxi mum 60 min after the injection and then decreased to zero about 120 min after the injection (Fig. 3A) . The treatment increased (25%) dopamine release in the ipsilateral stria tum from 25 min to about 100 min after the injection and then decreased (15%) it on that side till the end of the experiment (250 min after the injection). In contrast, the treatment decreased dopamine release in the contralateral striatum throughout the measurement period (Fig. 3B ).
D isc u ssio n
Previous studies in which an identical dialysis technique was used (Takada et al., 1993; Tomiyama et al., 1993) have shown that the baseline dopamine concentration mea sured in the dialysate of striatally perfused rats which received their implantation at least 7 days earlier, is largely dependent on neuronal activity as more than 80% of the dopamine release has been found to be tetrodotoxin-sensitive and Ca2 '^dependent. The results of the present study show that stimulation of acetylcholine or dopamine recep tors in the nucleus accumbens produced significant changes in this dopamine release in the ventrolateral striatum. The finding that the two treatments had differential effects on the dopamine release in the ipsilateral and contralateral striatum together with the finding that saline injections into the nucleus accumbens (controls) did not affect the dopamine release in the left or right striatum clearly indicates that the drug-induced changes in dopamine re lease were not artifacts of the technique utilized for esti mating the release of dopamine.
Although future studies are required to prove that the drug-induced changes found in the present study are also tetrodotoxin-sensitive an d /o r Ca2+-dependent, it is un likely that these changes were independent of alterations in neuronal activity. Apart from the highly speculative idea that different brain structures may transmit messages to each other via glial cells or neuroendocrine processes, there is hard evidence that the nucleus accumbens both directly and indirectly via the ventral pallidum projects to the A 9 cell area (Groenewegen et al., 1991; Wouterlood et al., 1992; Zahm and Heimer, 1993) which, in turn, inner vates the ipsilateral and contralateral striatum (Fass and Butcher, 1981) . Given this and related anatomical connec tions (see below), it is therefore suggested that the drug-in duced changes in the ventrolateral striatum were due to alterations in neuronal activity.
The present study clearly shows that the chosen treat ments, which directly alter neurotransmission in the nu cleus accumbens, a structure known to be involved in the process of locomotion , also caused clearcut changes in the striatum, a structure known to be involved in postural asymmetry (Kelly and Moore, 1976; Moore and Kelly, 1977; Pycock and Marsden, 1978; Pycock, 1980) . The finding that both the cholinergic and the dopaminergic treatment of the nucleus accumbens produced the greatest increase in dopamine release in the striatum ipsilateral to the drug injection site in the nucleus accumbens provides an unequivocal expla nation for the observation that both treatments resulted in contralateral turning, since rats with a functional imbalance between the left and right striatum are known to turn away from the side with the higher dopamine activity (Ungerstedt, 1971) . Still, the carbachoi-treated rats stopped their contralateral turning long before the increased dopamine release returned to baseline levels. This lack of correlation between the biochemical and the behavioural effects of a particular drug treatment has often been seen (Di Chiara and Imperato, 1988) . This phenomenon is not understood. This finding rules out the possibility that the increase in dopamine release was simply the consequence of the be haviour shown: dopamine release remained high despite the lack of turning in the carbachoi-treated rats. One can only speculate about the functional meaning of the persis tent increase in dopamine release. Apart from the theoreti cal possibility that it might have been due to non-neuronal processes, it is possible that carbachol injected into the nucleus accumbens activated an additional neuronal sys tem in the nucleus accumbens, which could have obscured the behavioural expression of the increased dopamine re lease in the striatum. Future studies are required to solve this problem. The finding that the dopaminergic treatment N. Koshikawa et ni / European Journal of Pharmacology 303 ( 1996) 13-19 of the nucleus ac cum bens produced an overall imbalance in dopamine release between the left and right striatum that correlated nicely with the contralateral turning ( Fig.  3C ; see also below), however, reveals that unilateral stri atal dopamine is required to be released in direct relation to the direction of turning. Taking these data together, it is concluded that the asymmetrical dopamine release in the striatum is indeed the signal to adopt an asymmetrical differences in dopamine release between the cholinergic and dopaminergic treatment of the nucleus accumbens strengthen the above-mentioned hypothesis that two dis tinct neurobiological substrates and/or mechanisms are involved in the phenomena found.
In summary, the present study provides biochemical evidence that stimulation of acetylcholine or dopamine receptors in the nucleus accumbens differentially alters Acknowledgements This work was supported by the Sato Fund (Japan) References posture. This together with the fact that the cholinergic or dopamine release in the ventrolateral part of the striatum, dopaminergic treatment of the nucleus accumbens provides the signal to move forwards Cools, 1977) explains why all rats displayed con tralateral turning after unilateral injections of cholinergic or dopaminergic agonists into the nucleus accumbens.
The effects of the cholinergic treatment of the nucleus accumbens on the dopamine release in the striatum were limited to one side of the brain, viz. the side of the accumbens injection, implying that a direct or indirect projection from the nucleus accumbens to the ipsilateral striatum is sufficient for mediating these biochemical ef fects. In contrast, the effects of the dopaminergic treatment of the nucleus accumbens on the dopamine release in the striatum extended to both sides of the brain, implying that a direct or indirect projection from the nucleus accumbens to both the left and the right striatum is required for mediating these biochemical effects. Although the nature of these connections remains to be determined, there are at least three candidates in this respect: (a) the pathway which connects the nucleus accumbens via the A 10 cells in the ventral tegmental region with the ventrolateral striatum (Loughlin and Fallon, 1982; Heimer et al., 1991; Zahm and Heimer, 1993) , (b) the pathway which connects the nucleus accumbens via the A 9 cells in the substantia nigra pars compacta with the ventrolateral striatum (Fass and Butcher, 1981; Groenewegen et al., 1991; Wouterlood et al., 1992; Zahm and Heimer, 1993) , and (c) the pathway which connects the nucleus accumbens via pallido-nigral fibres with the ventrolateral striatum Heimer, 1990, 1993) . Future studies are required to determine whether these pathways are indeed differentially involved in the effects found in the present study. Anyhow, the above-mentioned data provide biochemical evidence that at least two distinct pathways are required in order to mediate the effects of the cholinergic and dopaminergic treatment (Koshikawa, 1994; Saigusa et al., 1995) . The effects of the cholinergic treatment of the nucleus accum bens on dopamine release in the striatum differed from those of the dopaminergic treatment of the nucleus accum bens in two additional aspects. First, the effects of the cholinergic treatment were much greater and longer-lasting than those of the dopaminergic treatment. And, second, analysis of the time relationship between the biochemical and behavioural effects shows that the cholinergic treat ment did not produce biochemical changes which corre lated with the contralateral turning, whereas the dopamin ergic treatment did ( Fig. 2C and Fig. 3C ), These additional
